Holen Sie sich die Stockscreener-App
3.44
7.17%
0.23
Schlusskurs vom Vortag:
$3.21
Offen:
$3.27
24-Stunden-Volumen:
15,384
Relative Volume:
0.48
Marktkapitalisierung:
$11.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.69M
KGV:
-0.4858
EPS:
-7.0818
Netto-Cashflow:
$-9.07M
1W Leistung:
-9.47%
1M Leistung:
-14.00%
6M Leistung:
-39.65%
1J Leistung:
-49.04%
1-Tages-Spanne:
$3.2101
$3.45
1-Wochen-Bereich:
$3.21
$3.90
52-Wochen-Spanne:
$3.21
$43.50
Intensity Therapeutics Inc Stock (INTS) Company Profile
Firmenname
Intensity Therapeutics Inc
Sektor
Branche
Telefon
203-221-7381
Adresse
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Compare INTS vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
3.44 | 12.41M | 0 | -10.69M | -9.07M | -7.0818 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten
Why Did INTS Stock Plummet 25% Today? - Stocktwits
symbol__ Stock Quote Price and Forecast - CNN
Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Ocugen (OCGN) - The Globe and Mail
Intensity Therapeutics, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (INTS) - Traders Union
Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga España
Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE) - The Globe and Mail
Intensity Therapeutics at H.C. Wainwright conference: data, cash and catalysts - Investing.com
Intensity Therapeutics at H.C. Wainwright conference: data, cash and catalysts By Investing.com - Investing.com Canada
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
All You Need to Know About Actuate Therapeutics, Inc. (ACTU) Rating Upgrade to Buy - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's After-Market Session - Sahm
Intensity (INTS) Quarterly Scorecard: EPS Comes in Above Forecast in the Latest Reading; Shares Close 0.41% Lower at the CloseForward EPS Estimate - vinanet.vn
Intensity (INTS) Snapshot: Moves 0.41% Down to $4.86; Immediate View: the Current Price Sits Inside the Supplied Technical Range on the DayLate Stage Breakouts - vinanet.vn
Intensity (INTS) Quarterly Results: Profit Per Share Clears Its Benchmark; Closing Reaction: Shares Move 0.41% LowerEarnings Call Q&A - careplusvn.com
Intensity (INTS) Move: Ends Lower by 0.41% at $4.86 in the Current Update; Technical View: Support at $4.62 and Resistance at $5.10 Frame the Range on the DayTechnical Analysis Picks - dars.gov.et
Intensity (INTS) Results Review: EPS Comes in Above Forecast in the Current Update - vinanet.vn
H.C. Wainwright Maintains Intensity Therapeutics(INTS.US) With Buy Rating, Maintains Target Price $7 - Moomoo
H.C. Wainwright reiterates Buy on Intensity Therapeutics stock By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Buy on Intensity Therapeutics stock - Investing.com
Analysts Offer Insights on Healthcare Companies: Quoin Pharmaceuticals (QNRX) and Pliant Therapeutics (PLRX) - The Globe and Mail
INTS Stock Price, Quote & Chart - ChartMill
INTENSITY THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $7 FROM $5 - Bitget
INTS Maintained by HC Wainwright & Co. -- Price Target Raised to $7.00 - GuruFocus
H.C. Wainwright Maintains Intensity Therapeutics(INTS.US) With Buy Rating, Cuts Target Price to $7 - Moomoo
Intensity Therapeutics (INTS) Dips 1% to $3.96, Trading Range Holds with Support at $3.76Zero Lag EMA - vinanet.vn
Earnings call transcript: Intensity Therapeutics misses Q2 2026 EPS as shares slip premarket - Investing.com UK
Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript - aol.com
Intensity Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
A. G. P. Maintains Intensity Therapeutics(INTS.US) With Buy Rating, Cuts Target Price to $15 - Moomoo
Intensity Therapeutics Warns of Substantial Doubt - minichart.com.sg
Intensity Therapeutics Q2 Results: EPS loss narrows 67% YoY - scanx.trade
INTS: Q2 2026 saw higher R&D spend, resumed trial enrollment, and strong early TNBC efficacy data - TradingView
Transcript : Intensity Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
Form 8K Intensity Therapeutics Inc For: 11 August By Investing.com - Investing.com Australia
INTS: Net loss rose 19% to $3M as clinical trials resumed, with $9.5M cash and $30M more needed for completion - TradingView
Intensity Therapeutics (INTS) Advances Clinical Trials Amidst Ch - GuruFocus
Intensity Therapeutics Reports $3.0 Million Q2 Net Loss - Quiver Quantitative
Intensity Therapeutics reports Q2 2026 net loss of $3.0M, cash $9.5M; resumes select trial enrollment - TradingView
Intensity Therapeutics Q2 net loss widens as R&D costs rise - TradingView
INTS: Resumed clinical trial enrollment and raised capital, with improved early TNBC study results - TradingView
BRIEF-Intensity Therapeutics Q2 Operating Income USD -3.084 Million - TradingView
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - PR Newswire
INTENSITY THERAPEUTICS, INC. Q2 2026: Net income $(3.0M), EPS $(1.11) — 10-Q Summary - TradingView
INTS Q2'26 Earnings: EPS estimate is (0.87) USD - TradingView
BRIEF-Intensity Therapeutics Q1 Operating Income USD -2.526 Million - TradingView
Intensity Therapeutics (INTS.US) will release its earnings report on August 11. - Moomoo
Intensity Therapeutics Inc (INTS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intensity Therapeutics Inc (INTS) Stock News Today - TradingKey
INTS Q1 2026 Earnings: Narrower Loss Beats Estimates; Shares Rise 1.64%Interim Report - dars.gov.et
Intensity Therapeutics (INTS.US) will release its earnings report before the market opens on August 11. - Moomoo
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 - Yahoo Finance
Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):